CO-REGULATION OF MACROPHAGE INFLAMMATORY PHENOTYPE BY IRF5 AND RELA

IRF5 和 RELA 对巨噬细胞炎症表型的共同调控

基本信息

  • 批准号:
    MR/J001899/1
  • 负责人:
  • 金额:
    $ 42.69万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2012
  • 资助国家:
    英国
  • 起止时间:
    2012 至 无数据
  • 项目状态:
    已结题

项目摘要

Inflammation is a normal and self-limiting physiological response to infection and injury but can lead to extensive tissue damage and disability when elicited in excess or sustained. Pathological consequences of chronic inflammatory responses include a variety of diseases with huge social impact ranging from autoimmune diseases, such as rheumatoid arthritis to many forms of cancer. Macrophages are cells of the immune system which patrol the body and have the ability to recognise a number of different signals released during infection and damage. They are of central importance in the pathogenesis of chronic inflammatory diseases. Depending on the type of signal they receive, macrophages can acquire "aggressive" inflammatory phenotype and will destroy invading threats and defective cells. They secrete inflammatory molecules and set up an environment for expansion of other types of immune cells with inflammation propagating features. Other signals give rise to more "peaceful" macrophages that promote the growth and repair of damaged regions. For example, synovial lesions in rheumatoid arthritis are characterised by the pre-dominant presence of aggressive macrophages. Recently my laboratory has made a potentially therapeutically important discovery and identified a molecular switch, called 'IRF5' that controls the aggressive phenotype of macrophages: it is highly expressed in aggressive macrophages and induces a characteristic gene expression and inflammatory molecule secretion profile. It is crucially important for establishing an inflammatory environment, associated with a number of autoimmune and inflammatory diseases, and promotes development of memory immune cells which produce even more harmful inflammatory mediators. We have also explored modes of IRF5 regulatory function and demonstrated that they involve functional and physical interactions with another molecular switch, called NF-kB RelA, which is important for proper immune function of both aggressive and peaceful macrophages. This project will test the hypothesis that interfering with IRF5, and in particular with its interactions with RelA, will override signals influencing aggressive macrophage development at sites of inflammation and promote their transformation into more peaceful phenotype, thus reducing inflammation. Our aim is to ascertain: 1. which inflammatory molecules produced by aggressive macrophages are regulated by IRF5 and RelA and how is this control achieved on the molecular level? 2. can we block direct interactions between IRF5 and RelA and would this reduce production of the inflammatory molecules identified above?The outcome of this study is expected to be the proof-of-principle demonstration of a new approach to controlling sustained inflammatory cytokine production, based on modulation of the recently identified major molecular switch. The follow up studies will look into the possibilities of other ways of modulating its activity and function, using chemicals, amendable to drug development. Taking account the essential role of macrophages in any immune and inflammatory condition, identification of major molecular switches that determine aggressive or peaceful function of macrophages may hold the key to new therapeutic interventions. It is an important area of research, as it may result in new class of treatment for a wide range of immune conditions. For example, blocking the function of these switches would dampen down damaging inflammation present in autoimmune diseases, while alternatively, inducing their function would boost the immune system in people with immunosuppression.
炎症是对感染和损伤的正常且自限性的生理反应,但过度或持续时可导致广泛的组织损伤和残疾。慢性炎症反应的病理后果包括多种具有巨大社会影响的疾病,从类风湿性关节炎等自身免疫性疾病到多种癌症。巨噬细胞是免疫系统的细胞,在身体中巡逻,能够识别感染和损伤期间释放的许多不同信号。它们在慢性炎症性疾病的发病机制中至关重要。根据它们接收到的信号类型,巨噬细胞可以获得“攻击性”炎症表型,并摧毁入侵的威胁和有缺陷的细胞。它们分泌炎症分子,并为具有炎症传播特征的其他类型免疫细胞的扩张建立环境。其他信号会产生更“和平”的巨噬细胞,促进受损区域的生长和修复。例如,类风湿性关节炎的滑膜损伤的特征在于主要存在侵袭性巨噬细胞。最近,我的实验室取得了一项潜在的重要治疗发现,并确定了一种称为“IRF5”的分子开关,它控制巨噬细胞的侵袭性表型:它在侵袭性巨噬细胞中高度表达,并诱导特征性基因表达和炎症分子分泌谱。它对于建立与许多自身免疫和炎症疾病相关的炎症环境至关重要,并促进记忆免疫细胞的发育,从而产生更多有害的炎症介质。我们还探索了 IRF5 调节功能的模式,并证明它们涉及与另一种分子开关(称为 NF-kB RelA)的功能和物理相互作用,这对于攻击性巨噬细胞和和平巨噬细胞的正常免疫功能都很重要。该项目将测试以下假设:干扰 IRF5,特别是其与 RelA 的相互作用,将覆盖影响炎症部位侵袭性巨噬细胞发育的信号,并促进其转化为更和平的表型,从而减少炎症。我们的目的是确定: 1. 侵袭性巨噬细胞产生的哪些炎症分子受到 IRF5 和 RelA 的调节,这种控制是如何在分子水平上实现的? 2.我们能否阻断IRF5和RelA之间的直接相互作用,这是否会减少上面确定的炎症分子的产生?这项研究的结果预计将成为基于最近确定的主要分子开关的调节的控制持续炎症细胞因子产生的新方法的原理证明。后续研究将探讨使用适合药物开发的化学物质调节其活性和功能的其他方法的可能性。考虑到巨噬细胞在任何免疫和炎症条件下的重要作用,确定决定巨噬细胞攻击性或和平功能的主要分子开关可能是新治疗干预措施的关键。这是一个重要的研究领域,因为它可能会为多种免疫疾病带来新的治疗方法。例如,阻断这些开关的功能将抑制自身免疫性疾病中存在的破坏性炎症,而诱导它们的功能将增强免疫抑制患者的免疫系统。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IRF5 is a specific marker of inflammatory macrophages in vivo.
  • DOI:
    10.1155/2013/245804
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Weiss M;Blazek K;Byrne AJ;Perocheau DP;Udalova IA
  • 通讯作者:
    Udalova IA
Macrophage activation and polarization: nomenclature and experimental guidelines.
  • DOI:
    10.1016/j.immuni.2014.06.008
  • 发表时间:
    2014-07-17
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Murray, Peter J.;Allen, Judith E.;Biswas, Subhra K.;Fisher, Edward A.;Gilroy, Derek W.;Goerdt, Sergij;Gordon, Siamon;Hamilton, John A.;Ivashkiv, Lionel B.;Lawrence, Toby;Locati, Massimo;Mantovani, Alberto;Martinez, Fernando O.;Mege, Jean-Louis;Mosser, David M.;Natoli, Gioacchino;Saeij, Jeroen P.;Schultze, Joachim L.;Shirey, Kari Ann;Sica, Antonio;Suttles, Jill;Udalova, Irina;van Ginderachter, Jo A.;Vogel, Stefanie N.;Wynn, Thomas A.
  • 通讯作者:
    Wynn, Thomas A.
IRF5:RelA interaction targets inflammatory genes in macrophages.
  • DOI:
    10.1016/j.celrep.2014.07.034
  • 发表时间:
    2014-09-11
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Saliba DG;Heger A;Eames HL;Oikonomopoulos S;Teixeira A;Blazek K;Androulidaki A;Wong D;Goh FG;Weiss M;Byrne A;Pasparakis M;Ragoussis J;Udalova IA
  • 通讯作者:
    Udalova IA
Macrophages: Biology and Role in the Pathology of Diseases
巨噬细胞:生物学及其在疾病病理学中的作用
  • DOI:
    10.1007/978-1-4939-1311-4_22
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Eames H
  • 通讯作者:
    Eames H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Irina Udalova其他文献

Irina Udalova的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Irina Udalova', 18)}}的其他基金

Shaping the neutrophil: morphological, genomic, and functional maturation
塑造中性粒细胞:形态、基因组和功能成熟
  • 批准号:
    BB/Y004752/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Research Grant
Targeted modulation of neutrophil activity: impact on intestinal immunopathology
中性粒细胞活性的靶向调节:对肠道免疫病理学的影响
  • 批准号:
    MR/X000605/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Research Grant
SYSTEMATIC QUANTITATIVE ANALYSIS OF NF-kappaB CO-ACTIVATORS
NF-κB 共激活剂的系统定量分析
  • 批准号:
    G0700818/1
  • 财政年份:
    2007
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Research Grant
DISSECTING THE FUNCTION OF INDIVIDUAL NF-kappaB SUBUNITS IN INFLAMMATION
剖析单个 NF-kappaB 亚基在炎症中的功能
  • 批准号:
    G0501087/1
  • 财政年份:
    2006
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Research Grant

相似海外基金

Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
  • 批准号:
    10629550
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
Dissecting macrophage regulation of lung epithelial regeneration
剖析巨噬细胞对肺上皮再生的调节
  • 批准号:
    MR/X019314/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Fellowship
Hypoxic regulation of macrophage migration and function via fibroblast reprogramming in pancreatic cancer
通过胰腺癌成纤维细胞重编程对巨噬细胞迁移和功能的缺氧调节
  • 批准号:
    10677376
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
Macrophage-mediated regulation of inflammation and tissue repair
巨噬细胞介导的炎症和组织修复调节
  • 批准号:
    10714025
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD
CKD 中铁蛋白重链对巨噬细胞表型的调节
  • 批准号:
    10562610
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
Regulation of the melanoma microenvironment by the macrophage molecular switch PI3Kgamma
巨噬细胞分子开关PI3Kgamma对黑色素瘤微环境的调节
  • 批准号:
    23K07752
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Type II alveolar epithelial cell regulation of alveolar macrophage development, metabolism and immune function by a novel NKR-P1:Clr interaction.
II 型肺泡上皮细胞通过新型 NKR-P1:Clr 相互作用调节肺泡巨噬细胞的发育、代谢和免疫功能。
  • 批准号:
    488876
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Operating Grants
Pathophysiology determination of peri-implantitis based on macrophage hierarchy and regulation of tissue alignment
基于巨噬细胞层次结构和组织排列调节的种植体周围炎的病理生理学测定
  • 批准号:
    23H03093
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of Aging on Oxysterol Regulation of Alveolar Macrophage Function during S. pneumoniae
衰老对肺炎链球菌期间肺泡巨噬细胞功能的氧甾醇调节的影响
  • 批准号:
    10737015
  • 财政年份:
    2023
  • 资助金额:
    $ 42.69万
  • 项目类别:
Nrf2 regulation of alveolar macrophage immune responses in vivo to Mycobacterium tuberculosis
Nrf2 调节肺泡巨噬细胞对结核分枝杆菌的体内免疫反应
  • 批准号:
    10555299
  • 财政年份:
    2022
  • 资助金额:
    $ 42.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了